Live from the NIH registry
Studies recruiting near Honolulu right now
Top 25 of 201 recruiting studies, sorted by proximity — each links to its official registry page
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
The Queen's Medical Center - POB I — Honolulu, Hawaii (1.7 mi)
· Sponsor: American Society of Clinical Oncology
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
Prediabetic State, Atherosclerosis
Phase 4
Interventional 7,410 participants sought
VA Pacific Islands Health Care System, Honolulu, HI — Honolulu, Hawaii (1.7 mi)
· Sponsor: VA Office of Research and Development
Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study
Colorectal Adenocarcinoma, Stage I Colorectal Cancer AJCC v8
N/A
Observational 1,000 participants sought
The Queen's Medical Center — Honolulu, Hawaii (1.7 mi)
· Sponsor: M.D. Anderson Cancer Center
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Kapiolani Medical Center for Women and Children — Honolulu, Hawaii (1.7 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Honolulu, Hawaii (1.7 mi)
· Sponsor: Sameek Roychowdhury
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid Tumors, Hematologic Malignancies
Phase 3
Interventional 3,500 participants sought
Kaiser Permanente Moanalua Medical Center ( Site 0063) — Honolulu, Hawaii (1.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Pacific Diabetes & Endocrine Center /ID# 259030 — Honolulu, Hawaii (1.7 mi)
· Sponsor: AbbVie
The PROmoting Pain Self-Management (PROs) Trial: Holistic Pain Care in the Military Health System
Chronic Pain, Musculoskeletal Pain
N/A
Interventional 608 participants sought
Desmond Doss Health Clinic — Schofield Barracks, Hawaii (18.3 mi)
· Sponsor: Brooke Army Medical Center
Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
Phase 2
Interventional 15 participants sought
Adverum site 149 — ‘Aiea, Hawaii (6.7 mi)
· Sponsor: Adverum Biotechnologies, Inc.
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 626 participants sought
Local Institution - 007-897 — Honolulu, Hawaii (1.7 mi)
· Sponsor: Mirati Therapeutics Inc.
Function After Anterior Cervical Discectomy and Fusion Surgery: Timing of Physical Therapy
Cervical Spine Degeneration, ACDF Surgery
N/A
Interventional 76 participants sought
Tripler Army Medical Center — Honolulu, Hawaii (1.7 mi)
· Sponsor: Vanderbilt University Medical Center
Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
AMI Cardiogenic Shock
N/A
Observational 350 participants sought
Straub Benioff Medical Center — Honolulu, Hawaii (1.7 mi)
· Sponsor: Abiomed Inc.
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
Estrogen Receptor Negative, HER2 Positive Breast Carcinoma
N/A
Interventional 120 participants sought
Queen's Medical Center — Honolulu, Hawaii (1.7 mi)
· Sponsor: M.D. Anderson Cancer Center
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
Kapiolani Medical Center for Women and Children — Honolulu, Hawaii (1.7 mi)
· Sponsor: National Cancer Institute (NCI)
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
Overweight, Obesity
Phase 3
Interventional 285 participants sought
East West Med Res Inst — Honolulu, Hawaii (1.7 mi)
· Sponsor: Novo Nordisk A/S
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1, Phase 2
Interventional 960 participants sought
Kapiolani Medical Center for Women and Children — Honolulu, Hawaii (1.7 mi)
· Sponsor: PedAL BCU, LLC
A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast Cancer
Breast Neoplasm
N/A
Observational 330 participants sought
Univercity of Hawaii Cancer Center — Honolulu, Hawaii (1.7 mi)
· Sponsor: EXoPERT
Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer
Hepatocellular Carcinoma (HCC)
Phase 1
Interventional 15 participants sought
The Queen's Medical Center — Honolulu, Hawaii (1.7 mi)
· Sponsor: University of Hawaii
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
Pacific Diabetes & Endocrine Center — Honolulu, Hawaii (1.7 mi)
· Sponsor: Boehringer Ingelheim
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Obesity, Overweight
Phase 3
Interventional 3,200 participants sought
East-West Medical Research — Honolulu, Hawaii (1.7 mi)
· Sponsor: Amgen
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 335 participants sought
Hawaii Cancer Care Inc - Waterfront Plaza — Honolulu, Hawaii (1.7 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8
Phase 3
Interventional 474 participants sought
Hawaii Cancer Care Inc - Waterfront Plaza — Honolulu, Hawaii (1.7 mi)
· Sponsor: NRG Oncology
Poi for Mama: a Pilot to Improve Maternal Microbiome and Gestational Diabetes Risk
Gestational Diabetes Mellitus (GDM), Pregnancy
N/A
Interventional 50 participants sought
University of Hawai'i Cancer Center — Honolulu, Hawaii (1.7 mi)
· Sponsor: University of Hawaii
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Kapiolani Medical Center for Women and Children — Honolulu, Hawaii (1.7 mi)
· Sponsor: Children's Oncology Group
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Adjustment Disorder
Phase 2
Interventional 100 participants sought
Hawaii Pacific Neuroscience — Honolulu, Hawaii (1.7 mi)
· Sponsor: Reunion Neuroscience Inc